Skip to Content

Join the 'Eplerenone' group to help and get support from people like you.

Eplerenone News

Doctor-Patient Dialogue May Boost Use of Blood Pressure Drugs

Posted 22 Aug 2017 by Drugs.com

TUESDAY, Aug. 22, 2017 – Doctors can help boost use of high blood pressure medications by their poor patients simply by talking to them, a new study suggests. Many people fail to take their blood pressure-lowering drugs, putting them at higher risk of heart attack and stroke, the American Heart Association says. But by communicating more effectively and talking to patients about their specific challenges, physicians may improve medication use, researchers found. "Health care providers should talk to patients about the things that get in the way of taking their medication, such as relationship status, employment and housing," said Antoinette Schoenthaler, the study's lead author. "Unemployment, for example, affects whether patients can afford medication, which is a primary risk factor for non-adherence," said Schoenthaler, an associate professor of medicine at New York University School ... Read more

Related support groups: High Blood Pressure, Lisinopril, Hypertension, Metoprolol, Atenolol, Heart Disease, Losartan, Benicar, Diovan, Spironolactone, Bystolic, Ramipril, Bisoprolol, Cozaar, Valsartan, Micardis, Enalapril, Benazepril, Toprol-XL, Avapro

Many People Don't Take Their High Blood Pressure Meds: Study

Posted 7 Mar 2017 by Drugs.com

MONDAY, March 6, 2017 – Only 20 percent of patients seeking care for stubborn high blood pressure take all the medicine they're supposed to, a new Dutch study finds. "Another 20 percent are not taking any of their blood pressure medications," study senior author Dr. Peter Blankestijn said in an American Heart Association news release. As a result, patients sought care for a condition they could have addressed by simply following their doctor's orders, the findings suggested. "People mistakenly thought to have resistant hypertension – which is high blood pressure despite taking three or more medications – end up seeing specialists and undergoing extra tests because we don't understand why they are so difficult to treat," said Blankestijn. He is a professor of nephrology and hypertension at the University Medical Center Utrecht in the Netherlands. The researchers didn't set out to ... Read more

Related support groups: High Blood Pressure, Lisinopril, Hypertension, Metoprolol, Amlodipine, Atenolol, Hydrochlorothiazide, Spironolactone, Diltiazem, Lasix, Bystolic, Norvasc, Furosemide, Verapamil, Ramipril, Bisoprolol, Nifedipine, Enalapril, Cardizem, Benazepril

Calcium Buildup in Young Arteries May Signal Heart Attack Risk

Posted 8 Feb 2017 by Drugs.com

WEDNESDAY, Feb. 8, 2017 – Young adults with any amount of calcified plaque in their arteries are already at risk of a heart attack, a new study finds. Among those 32 to 46 years old, even a little calcified plaque – called atherosclerosis, or hardening of the arteries – can boost the odds for fatal or nonfatal heart disease fivefold over the next 12 years, researchers found. "Heart disease really begins in adolescence and early adulthood," said lead researcher Dr. Jeffrey Carr. Carr is a professor of radiology, biomedical informatics and cardiovascular medicine at Vanderbilt University in Nashville, Tenn. For the study, CT scans, which can detect these potentially deadly blockages, were performed on more than 3,000 participants whose average age was 40. Just a small amount of plaque increased the risk of heart attack over the next decade by 10 percent, regardless of other risk ... Read more

Related support groups: Obesity, High Blood Pressure, Lisinopril, Hypertension, Metoprolol, Smoking, Atenolol, Ischemic Stroke, Heart Disease, Losartan, High Cholesterol, Heart Attack, Propranolol, Benicar, Heart Failure, Diovan, Congestive Heart Failure, Spironolactone, Lasix, Bystolic

Know Your Heart's Numbers

Posted 7 Feb 2017 by Drugs.com

TUESDAY, Feb. 7, 2017 – More than two-thirds of Americans fret about heart disease, but few know the specific information that can help them boost their heart health, a new survey finds. "Studies have suggested the majority of coronary artery disease events can be prevented by addressing treatable risk factors," said Dr. Steve Nissen, chair of cardiovascular medicine at the Cleveland Clinic. "That means, a little knowledge regarding your 'numbers' could go a long way to helping keep your heart healthy and avoiding future problems," he added in a clinic news release. Treatable risk factors for heart disease include blood pressure, cholesterol, body mass index (BMI - an estimate of body fat based on height and weight), waist circumference, blood sugar and weight. The telephone survey of just over 1,000 adults, aged 18 and older, found that 68 percent were worried about heart disease. But ... Read more

Related support groups: High Blood Pressure, Lisinopril, Hypertension, Vitamins, Metoprolol, Atenolol, Heart Disease, Losartan, High Cholesterol, Benicar, Multivitamin, Diovan, Spironolactone, Lasix, Bystolic, Furosemide, Ramipril, Bisoprolol, Fish Oil, Multivitamin With Minerals

Heart Risks May Boost Women's Colon Cancer Risk, Too

Posted 1 Feb 2017 by Drugs.com

WEDNESDAY, Feb. 1, 2017 – Even normal-weight women may be at greater risk for colon cancer if they have certain traits, such as elevated levels of blood fat, high blood sugar, high blood pressure and low levels of good cholesterol, a new study suggests. Among older women of normal weight, those with so-called metabolic risk factors had a 49 percent increased risk for cancers of the colon, rectum and sigmoid colon (the lower part of the intestine connecting the rectum and colon) compared with healthy counterparts. Current guidelines recommend colon cancer screening primarily based on a person's age. But identifying at-risk individuals by their metabolic type could help prevent these cancers and catch them at an earlier stage, saving more lives, the study authors concluded. The takeaway: "Know your own metabolic health, even if your weight is normal," said Juhua Luo, the study's senior ... Read more

Related support groups: Obesity, High Blood Pressure, Cancer, Lisinopril, Hypertension, Heart Disease, Losartan, High Cholesterol, Heart Attack, Benicar, Diovan, Spironolactone, Ramipril, Cozaar, Valsartan, Micardis, Enalapril, Colorectal Cancer, Benazepril, Basal Cell Carcinoma

New Drugs Might Give Heart Patients an Edge

Posted 11 Mar 2013 by Drugs.com

SUNDAY, March 10 – In the search for better medicines to safely help heart patients, clinical trials testing three new drugs appear to offer some promise. Two of the drugs, cangrelor and inclacumab, might improve outcomes for patients undergoing cardiac interventions such as angioplasty or stenting, while a third drug, Inspra, seems to lower heart patients' odds for death and heart failure following a heart attack. All three trials were funded by the respective drugs' makers, and all three were presented Sunday at the annual meeting of the American College of Cardiology (ACC) in San Francisco. In the first trial, researchers compared an as-yet approved blood thinner called cangrelor against the current standard medication, Plavix (clopidogrel), for patients who have recently had a stent implanted in an artery to help improve blood flow. According to the ACC, more than 600,000 coronary ... Read more

Related support groups: Heart Attack, Heart Failure, Congestive Heart Failure, Myocardial Infarction, Cardiovascular Conditions and Disorders, Eplerenone, Inspra

Heart Failure Drugs Put to the Test

Posted 27 Nov 2012 by Drugs.com

TUESDAY, Nov. 27 – Two new studies examine the effectiveness of medications frequently prescribed for heart failure – the heart's inability to pump blood properly throughout the body. For the 5.7 million Americans who suffer from heart failure, shortness of breath and edema (excessive water retention) can hinder normal activities. Advances in medication have dramatically changed the lives of some patients, but the question facing cardiologists is: What drugs should they prescribe for this difficult-to-treat condition? "Treatment can be difficult because of low blood pressure or kidney disease," said study lead author Dr. Adrian Hernandez. "Other conditions such as depression make it harder for patients to adhere to their medications." And patients with heart failure "are at high risk for mortality or hospitalization for worsening heart failure," he explained. (About 55,000 die of ... Read more

Related support groups: Lisinopril, Heart Failure, Congestive Heart Failure, Spironolactone, Ramipril, Enalapril, Micardis, Benazepril, Perindopril, Telmisartan, Aldactone, Quinapril, Zestril, Vasotec, Lotensin, Altace, Captopril, Accupril, Prinivil, Fosinopril

Treatment Advances Improve the Odds for Heart Failure Patients

Posted 16 Feb 2012 by Drugs.com

THURSDAY, Feb. 16 – Although a growing number of Americans now struggle with heart failure, experts say new treatments have dramatically improved both quality of life and life expectancy for these patients. "The present environment for heart failure is substantially improved, and the future holds promises that will truly remove the term 'failure' from the description of this illness," said Dr. Gregg Fonarow, director of the Ahmanson-UCLA Cardiomyopathy Center in Los Angeles and co-director of the Preventive Cardiology Program at UCLA's David Geffen School of Medicine. Dr. Clyde Yancy, past president of the American Heart Association and chief of cardiology at Northwestern Memorial Hospital in Chicago, seconded that notion, pointing to what he sees as "the edge of a new dawn" in which advances in treatment will enable clinicians to "take the heft, the drama and the 'failure' out of ... Read more

Related support groups: Lisinopril, Heart Failure, Congestive Heart Failure, Spironolactone, Ramipril, Enalapril, Benazepril, Perindopril, Aldactone, Quinapril, Zestril, Vasotec, Lotensin, Altace, Captopril, Accupril, Prinivil, Fosinopril, Trandolapril, Monopril

Accidental Medication Poisonings in Kids on the Rise

Posted 16 Sep 2011 by Drugs.com

FRIDAY, Sept. 16 – Despite ongoing prevention efforts, a growing number of young children are being accidentally poisoned with medications, according to new research. The study, which was based on data reported to the American Association of Poison Control Centers between 2001 and 2008, found that medication poisoning among children aged 5 and under increased by 22 percent, although the number of children in the United States in this age group rose by only 8 percent during the study period. "The problem of pediatric poisoning in the U.S. is getting worse, not better," Dr. Randall Bond, of Cincinnati Children's Hospital Medical Center, said in a hospital news release. In conducting the study, which is scheduled for publication in the Journal of Pediatrics, the researchers reviewed information on over 544,000 children who landed in the emergency department due to medication poisoning ... Read more

Related support groups: Xanax, Suboxone, Oxycodone, Hydrocodone, Percocet, Methadone, Klonopin, OxyContin, Vicodin, Lisinopril, Norco, Clonazepam, Fentanyl, Ativan, Morphine, Ambien, Valium, Codeine, Metoprolol, Lortab

Ask a Question

Further Information

Related Condition Support Groups

Heart Failure, Congestive Heart Failure, High Blood Pressure, Hypertension

Related Drug Support Groups

Inspra

Eplerenone Patient Information at Drugs.com